Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03496077 · ClinicalTrials.gov registry record · NA

Addictive Potential of LCCs in Dual Users

A NA study, sponsored by UConn Health.

Completed
Registry status
NA
Development phase
65
Enrollment target

NCT03496077: Completed NA study, sponsored by UConn Health.

NCT03496077 is a NA study that has completed, run by UConn Health. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03496077, a NA study, has completed, sponsored by UConn Health.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target

Study Summary

This study is about whether or not little cigars and cigarillos cause or maintain addiction, and if flavors, such as fruit, make them more addictive. The purpose of this study is to understand the addiction potential of little cigars and cigarillos compared to cigarettes in young adults who smoke both products. This study will also look at the differences between men and women. In the rest of this form, little cigars or cigarillos will be referred to as LCCs.

Primary Outcome

Hypothetical consumption of LCCs as prices increase. These are the model-adjusted predicted mean values of elasticity, adjusted for covariates. It is the expected change in consumption for a one unit change in price.

Interventions

  • OTHER Flavored and unflavored little cigars/cigarillos (LCCs)

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2018-08-28
Est. Completion 2020-12-31
Phase NA
UConn Health

178 total trials

What the finished NCT03496077 record still lists

NCT03496077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Flavored and unflavored little cigars/cigarillos (LCCs) is the first listed.

NCT03496077 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03496077 about?

NCT03496077 is a clinical study titled "Addictive Potential of LCCs in Dual Users". This study is about whether or not little cigars and cigarillos cause or maintain addiction, and if flavors, such as fruit, make them more addictive. The purpose of this study is to understand the addiction potential of little cigars and cigarillos compared to cigarettes in young adults who smoke bo...

What is the current status of trial NCT03496077?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2018-08-28. Estimated completion is 2020-12-31.

What interventions are being tested in trial NCT03496077?

The interventions under investigation include: Flavored and unflavored little cigars/cigarillos (LCCs) (OTHER).

Who is sponsoring clinical trial NCT03496077?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03496077's enrollment target sits among peer trials

65 1144th of 2000 higher than 854 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03496077, the US trial registry maintained by the National Library of Medicine. NCT03496077 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.